Singapore markets open in 8 hours 46 minutes

Kamada Ltd. (KMDA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.28+0.06 (+1.11%)
As of 11:59AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close5.22
Open5.26
Bid0.00 x 0
Ask0.00 x 0
Day's range5.26 - 5.28
52-week range4.08 - 6.53
Volume1,166
Avg. volume21,137
Market cap307.269M
Beta (5Y monthly)0.24
PE ratio (TTM)35.19
EPS (TTM)0.15
Earnings date22 May 2024 - 27 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.00
  • GlobeNewswire

    Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

    REHOVOT, Israel and HOBOKEN, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that it will release financial results for the first quarter ended March 31, 2024, prior to the open of the U.S. financial markets on Wednesday, May 8, 2024. Kamada management will host an

  • Insider Monkey

    Kamada Ltd. (NASDAQ:KMDA) Q4 2023 Earnings Call Transcript

    Kamada Ltd. (NASDAQ:KMDA) Q4 2023 Earnings Call Transcript March 6, 2024 Kamada Ltd. beats earnings expectations. Reported EPS is $0.09, expectations were $0.05. KMDA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to Kamada Ltd.’s Fourth Quarter and […]

  • GlobeNewswire

    Kamada Issues 2024 CEO Letter to Shareholders

    REHOVOT, Israel, and HOBOKEN, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today issued a Letter to Shareholders from Amir London, Chief Executive Officer. Dear Shareholders, Colleagues and Business Partners: The recently completed 2023 was another successful period in our com